InvestorsHub Logo
Followers 276
Posts 32461
Boards Moderated 0
Alias Born 11/14/2013

Re: scotty3371 post# 209694

Wednesday, 01/23/2019 7:39:09 PM

Wednesday, January 23, 2019 7:39:09 PM

Post# of 689593
Anyway, as #28 made the top eight, but was not included, I hope someone at the meeting might consider asking it. Even if it hadn't made the top eight, I'd hope someone might ask it.

In the DC Vax-L Phase III trial, how many efficacy Interim Analyses (IAs) were conducted and what type of information did NWBO receive concerning the efficacy IAs, including but not limited to whether or not the endpoints were statistically significant?


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News